Document:

Advisory and Consulting Agreement

 
Exhibit
4.1    Advisory and Consulting Agreement 
 

	 	    	 Number of Shares and Warrants

	 4.1(a)
	    	 10,000,000

	 4.1(b)
	    	 10,000,000

	 4.1(c)
	    	 10,000,000

	 4.1(d)
	    	 8,000,000

	 4.1(e)
	    	 1,000,000

	 4.1(f)
	    	 240,000

	 4.1(g)
	    	 1,131,000

	 4.1(h)
	    	 1,800,000

	 4.1(i)
	    	 791,000

	 4.1(j)
	    	 1,650,000

	 Other
	    	 200,000

	 	    	

	 Total
	    	 44,812,000

	 	    	

 

9Consulting Agreement - Howard Schraub

 
Exhibit 4.1(a) 
 
CONSULTING AGREEMENT 
 
AGREEMENT, effective as of the 24th day of March,
2003, between Calypte Biomedical Corporation, a Delaware Corporation (the “Company”), of 1265 Harbor Parkway, Alameda, CA 94502, and Howard Schraub, 8638 Rueffe Monte Carlo, La Jolla CA 92037 (“Consultant”). 
 
WHEREAS, THE Company desires the Consultant to provide
consulting services to the Company pursuant hereto and Consultant is agreeable to providing such services. 
 
NOW THEREFORE, in consideration of the premises and the mutual promises set forth herein, the parties hereto agree as follows:

 

	1.	 	Consultant shall serve as a consultant to assist the Company in general corporate activities including but not limited to the following areas:

 

	 	(a)	 	Research venues for foreign sales for the company’s products. 

 

	 	(b)	 	Assist in the foreign marketing of the company’s products. 

 

	 	(c)	 	Assist in locating foreign strategic partners. 

 

	2.	 	Term: The Company shall be entitled to Consultant’s services for reasonable times when and to the extent requested by, and subject to the direction of Mr.
Cataldo. The term of this Consulting Agreement began as of the date of this Agreement, and shall terminate on June 24, 2003. 

 

	3.	 	Reasonable travel and other expenses necessarily incurred by Consultant to render such services, and approved in advance by the Company, shall be reimbursed by the
Company promptly upon receipt of proper statements, including appropriate documentation, with regard to the nature and amount of those expenses. Those statements shall be furnished to the Company monthly at the end of each calendar month in the
Consulting Period during which any such expenses are incurred. Company shall pay expenses within fifteen (15) business days of the receipt of a request with appropriate documentation. 

 

	4.	 	In consideration for the services to be performed by Consultant, the Consultant will receive a warrant to purchase ten million, (10,000,000) shares of the common
stock of the Company at an exercise price of $0.025 cents per share. The warrant expires on June 24, 2003. 

 

	5.	 	The consultant will provide to Calypte’s Executive Chairman a written report of services rendered and results thereof within 30 days of the conclusion of this
contract. 

 

10 

 

	6.	 	It is the express intention of the parties that the Consultant is an independent contractor and not an employee or agent of the Company. Nothing in this agreement
shall be interpreted or construed as creating or establishing the relationship of employer and employee between the Consultant and the Company. Both parties acknowledge that the Consultant is not an employee for state or federal tax purposes. The
Consultant shall retain the right to perform services for others during the term of this agreement. 

 
6.1    The consulting services shall not involve and the consultant is not engaged in services in connection with the
offer or sale of securities in a capital-raising transaction for Calypte, and further, the consultant does not and will not directly or indirectly promote or maintain a market for Calypte’s securities. 
 

	7.	 	Neither this agreement nor any duties or obligations under this agreement may be assigned by the Consultant without the prior written consent of the Company.

 

	8.	 	This agreement may be terminated upon ten (10) days written notice by the Company. Notwithstanding any termination, the compensation, as outlined in Section 4, shall
be earned in full by the Consultant upon execution of this agreement. 

 

	9.	 	Any notices to be given hereunder by either party to the other may be given either by personal delivery in writing or by mail, registered or certified, postage
prepaid with return receipt requested. Mailed notices shall be addressed to the parties at the addressed appearing in the introductory paragraph of this agreement, but each party may change the address by written notice in accordance with the
paragraph. Notices delivered personally will be deemed communicated as of actual receipt; mailed notices will be deemed communicated as of two days after mailing. 

 

	10.	 	This agreement supersedes any and all agreements, either oral or written, between the parties hereto with respect to the rendering of services by the Consultant for
the Company and contains all the covenants and agreements between the parties with respect to the rendering of such services in any manner whatsoever. Each party to this agreement acknowledges that no representations, inducements, promises, or
agreements, orally or otherwise, have been made by any party, or anyone acting on behalf of any party, which are not embodied 

 

11 

herein, and that no other agreement, statement, or promise not contained in this agreement
shall be valid or binding. Any modification of this agreement will be effective only if it is in writing signed by the party to be charged. 
 

	11.	 	This agreement will be governed by and construed in accordance with the laws of the State of California, without regard to its conflicts of laws provisions; and the
parties agree that the proper venue for the resolution of any disputes hereunder shall be Alameda County, California. 

 

	12.	 	For purposes of this Agreement, Intellectual Property will mean (i) works, ideas, discoveries, or inventions eligible for copyright, trademark, patent or trade
secret protection; and (ii) any applications for trademarks or patents, issued trademarks or patents, or copyright registrations regarding such items. Any items of Intellectual Property discovered or developed by the Consultant (or the
Consultant’s employees) during the term of this Agreement will be the property of the Consultant, subject to the irrevocable right and license of the Company to make, use or sell products and services derived from or incorporating any such
Intellectual Property without payment of royalties. Such rights and license will be exclusive during the term of this Agreement, and any extensions or renewals of it. After termination of this Agreement, such rights and license will be nonexclusive,
but will remain royalty-free. Notwithstanding the preceding, the textual and/or graphic content of materials created by the Consultant under this Agreement (as opposed to the form or format of such materials) will be, and hereby are, deemed to be
“works made for hire” and will be the exclusive property of the Company. Each party agrees to execute such documents as may be necessary to perfect and preserve the rights of either party with respect to such Intellectual Property.

 

	13.	 	The written, printed, graphic, or electronically recorded materials furnished by the Company for use by the Consultant are Proprietary Information and are the
property of the Company. Proprietary Information includes, but is not limited to, product specifications and/or designs, pricing information, specific customer requirements, customer and potential customer lists, and information on Company’s
employees, agent, or divisions. The Consultant shall maintain in confidence and shall not, directly or indirectly, disclose or use, either during or after the term of this agreement, any Proprietary Information, confidential information, or know-how
belonging to the Company, whether or not is in written form, except to the extent necessary to perform services under this agreement. On termination of the Consultant’s services to the Company, or at the request of the Company before
termination, the 

 

12 

Consultant shall deliver to the Company all material in the Consultant’s possession
relating to the Company’s business. 
 

	14.	 	The obligations regarding Proprietary Information extend to information belonging to customers and suppliers of the Company about which the Consultant may have
gained knowledge as a result of performing services hereunder. 

 

	15.	 	The Consultant shall not, during the term of this agreement and for a period of one year immediately after the termination of this agreement, or any extension of it,
either directly or indirectly (a) for purposes competitive with the products or services currently offered by the Company, call on, solicit, or take away any of the Company’s customers or potential customers about whom the Consultant became
aware as a result of the Consultant’s services to the Company hereunder, either for the Consultant or for any other person or entity, or (b) solicit or take away or attempt to solicit or take away any of the Company’s employees or
consultants either for the Consultant or for any other person or entity. 

 

	16.	 	The Company will indemnify and hold harmless Consultant from any claims or damages related to statements prepared by or made by Consultant that are either approved
in advance by the Company or entirely based on information provided by the Company. 

 

	 Consultant:
 Howard Schraub
	 	 	 	 Company:
 Calypte Biomedical Corporation

	
	 /s/    Howard Schraub

	 	 	 	 By:
	 	 /s/    Richard Brounstein

	 	 	 	 	 	 	 Richard Brounstein
 Executive Vice President & CFO

 
 
 
 
 
 

13Amended Consulting Agreement - George Furla

 
Exhibit 4.1(b)

 
Amendment No. 2 to Consulting Agreement

Between Calypte Biomedical Corporation 
and George Furla 
 
This Agreement amends and modifies the Amended Consulting Agreement between Calypte Biomedical Corporation (“Calypte” or the “Company”) and George Furla (“Consultant”) dated February 14, 2003 and is
effective as of March 24, 2003. 
 
Whereas, the Company desires to
extend the time period during which Consultant will provide services to the Company pursuant to the above referenced Consulting Agreement and Consultant is agreeable to extending the time for providing such services. 
 
Now therefore, in consideration of the premises and mutual promises set forth
herein, the parties hereto agree as follows: 
 

	1.	 	The term of Consultant’s Consulting Agreement shall be extended and, by virtue of this Amendment, shall terminate on August 20, 2003 rather than May 20, 2003.

 

	2.	 	In consideration for the extension of the services to be performed by Consultant, the Company will immediately grant to Consultant a warrant to purchase 10,000,000
shares of the registered common stock of the Company at $0.025 per share, or an aggregate purchase price of $250,000. All compensation pursuant to the Consulting Agreement and this Amendment is fully earned upon execution of this amendment. The
warrant is immediately exercisable upon grant and will expire on June 24, 2003. 

 

	3.	 	The Consultant will provide to Calypte’s Executive Chairman a written report of services rendered and results thereof each 90 days of this extended contract
within 30 days of the contract’s quarter end. 

 

	4.	 	All other terms and conditions of the Amended Consultant Agreement dated February 14, 2003 remain unchanged. 

 

	 Consultant:
	 	 	 	 Calypte Biomedical Corporation

	
	 /s/    George Furla

	 	 	 	 By:
	 	 /s/    Richard D. Brounstein

	 George Furla
	 	 	 	 Richard Brounstein
 Executive Vice President & CFO

 
 
 
 

14

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00049-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00049-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00049-of-00352.parquet"}]]